Home Stryker


Surpass Evolve Flow Diverter Designed to Treat Brain Aneurysms Launches

This is the first 64-wire cobalt chromium flow diverter in the U.S. designed to re-direct blood flow and promote aneurysm healing. Surpass Evolve is Stryker's latest innovation in flow diversion and follows the launch of Surpass Streamline in late 2018.

Neuroform Atlas® Stent System Granted an Expanded Indication

Neuroform Atlas® Stent System is the first and only adjunctive stent approved for use in the posterior (back of the brain) circulation. Aneurysms in the posterior circulation rupture more frequently and are generally more difficult to treat.

Stryker Announces They Have Released their Emergency Relief Bed™: A Limited-Release Medical Bed to Support Sritical Needs During a Pandemic

The company has developed a low-cost, limited-release emergency response bed, Emergency Relief Bed™, to quickly aid healthcare providers with efficient care during the COVID-19 pandemic.

Stryker’s Advanced Guidance Technologies announces partnerships with Synaptive Medical and Ziehm Imaging

10/8/18: "We are committed to providing our customers with a complete solution for surgical guidance," said Lisa Kloes, General Manager of Stryker's Advanced Guidance Technologies business. "The partnerships with Synaptive Medical and Ziehm Imaging are an important step in that direction."

Newly Published Data Demonstrate Bone In-Growth Potential of Stryker’s 3D-Printed Tritanium® Cage

8/2/18: “The results of this study provide an evidence-based approach to decision-making regarding interbody materials for spinal fusion, as there is significant variability in the materials commonly used for interbody cages in spine surgery,” said Sigurd H. Berven, M.D., orthopaedic surgeon at the University of California, San Francisco. “The study showed the potential for bone in-growth into and around the Tritanium cages.”

Stryker Announced They Received US FDA Pre-market Approval for the Surpass Streamline™ Flow Diverter to Treat Large and Giant Unruptured Aneurysms

7/16/18: "Surpass Streamline is the first flow diverter indicated for large and giant posterior communicating artery aneurysms. These unruptured aneurysms are more challenging due to their location and surrounding anatomy. Having Surpass approved for this and other locations is an important advantage for physicians and patients," said Dr. Philip Meyers, Professor of Radiology and Neurological Surgery at New York Presbyterian/Columbia University Medical Center and Co-Principal Investigator for the SCENT Investigational Device Exemption (IDE) trial which provided clinical outcomes to support Surpass PMA approval.

Trevo™ Retriever: Stryker Reports First and Only Device Indicated for Acute Ischemic Stroke Treatment Up to 24 hours in Europe

5/7/18: "The 24-hour indication opens the treatment window to patients whose stroke would previously have progressed until all the brain tissue surrounding the affected arteries was dead, leaving them with a life of significant disabilities," said Dr. Raul Nogueira.

Stryker Brings The Mobility Zone™ and Joint Health Education to Houston Open

3/29/18: Official Joint Replacement Products of the PGA TOUR® and PGA TOUR Champions continues goal to educate tournament-goers on importance of joint health.